![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/astellas-announces-sponsored-research-agreement-with-umass-chan-medical-school-302177183.html
https://www.prnewswire.com/news-releases/astellas-coordinates-patient-advocacy-organization-pao-action-week-to-connect-patients-with-critical-resources-302168261.html
https://www.prnewswire.com/news-releases/us-fda-acknowledges-astellas-resubmission-of-biologics-license-application-for-zolbetuximab-and-sets-new-action-date-302160157.html
https://www.biospectrumasia.com/news/25/24274/astellas-partners-with-yaskawa-to-create-innovative-cell-therapy-ecosystem-in-japan.html
https://www.prnewswire.com/news-releases/astellas-announces-a-collaboration-with-yaskawa-to-create-an-innovative-cell-therapy-ecosystem-through-the-integration-of-pharmaceutical-and-robotics-technologies-302150776.html
https://www.fiercebiotech.com/biotech/bayer-lifts-lid-pivotal-data-ahead-filings-challenge-astellas-menopause-market
https://www.prnewswire.com/news-releases/astellas-showcases-scientific-advancements-across-its-oncology-portfolio-at-2024-asco-annual-meeting-302142824.html
https://www.prnewswire.com/news-releases/astellas-and-poseida-therapeutics-enter-into-research-collaboration-and-license-agreement-to-develop-novel-allogeneic-cell-therapies-in-oncology-302133127.html
https://www.prnewswire.com/news-releases/astellas-and-poseida-therapeutics-enter-into-research-collaboration-and-license-agreement-to-develop-novel-allogeneic-cell-therapies-in-oncology-302133826.html